Le Lézard
Classified in: Health
Subject: PDT

Allergy Partners Announces the opening of their Specialty Pharmacy


ASHEVILLE, N.C., July 8, 2020 /PRNewswire-PRWeb/ -- Allergy Partners is pleased to announce the opening of the Allergy Partners Specialty Pharmacy located in Asheville, North Carolina. The opening of the specialty pharmacy marks the culmination of a long effort by Allergy Partners and its partner, Diplomat Infusion Services (a division of Optum) to create a unique service for patients suffering from immunologic disorders. The goal of the Allergy Partners Specialty Pharmacy is quite simple: to provide our patients and their families with superior service and quality of care while closing gaps in continuity of care.

The pharmacy will initially focus on 3 disease states ? humoral immune deficiency (IVIG/SCIG), HAE, and alpha-1 antitrypsin deficiency. Over time, we anticipate expanding the formulary to other conditions/medications. The pharmacy will be licensed initially in North Carolina and begin serving patients in early July. Licensing in other states will roll out as quickly as state procedures permit.

Allergy Partners has partnered with Diplomat Specialty Infusions, a recognized leader in the field, to provide operational and technical support for the pharmacy. In bringing years of expertise to the table, Diplomat is working side by side with us to ensure that our patients have the best possible experience and outcomes.

We are very excited about the Allergy Partners Specialty Pharmacy and firmly believe it will improve the care we provide our patients We hope you share this enthusiasm! If so, we'd be delighted to discuss the new pharmacy further and see if we can be your specialty pharmacy. But, if you are currently receiving care from another pharmacy, are happy with their service, and prefer not to change, we completely understand. Your health and satisfaction are priority #1.

 

SOURCE Allergy Partners


These press releases may also interest you

at 03:05
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clinical trial with MH002 in the orphan disease...

at 03:00
Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it has extended the menu of DxI 9000 Immunoassay...

at 03:00
Viewpoint, the esteemed educational program hosted by distinguished actor Dennis Quaid, is pleased to announce a collaborative effort with Medical Aid International for an upcoming episode dedicated to transforming healthcare in Low and Middle Income...

at 02:35
SpikImm, a clinical-stage biotechnology company founded in 2021 by Truffle Capital in collaboration with Institut Pasteur and dedicated to the development of monoclonal antibodies to prevent viral infections in immunocompromised patients, today...

at 02:00
SSI Schaefer, a global leader in warehouse automation and cold-chain storage solutions, is announcing the results of its partnership with Noatum Logistics Middle East, an integrated regional end-to-end logistics services arm of Noatum, an AD...

at 01:48
The consignment of sulfuric acid originated from Young Poong's Seokpo Smelter adds to the operational risks for Korea Zinc Young Poong has passed the costs and risks associated with sulfuric acid management to Korea Zinc while backlash from the local...



News published on and distributed by: